Drug Type siRNA |
Synonyms Kylo-12 |
Target |
Mechanism APOC3 inhibitors(Apolipoprotein C-III inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dyslipidemias | IND Approval | CN | 06 Dec 2024 |